(Q34438895)

2 August 2017

1 reference

title

Computer-based de novo design of drug-like molecules (English)

1 reference

2 August 2017

2

Uli Fechner

0 references

Gisbert Schneider

series ordinal

1

object named as

Gisbert Schneider

1 reference

2 August 2017

Uli Fechner

2

1 reference

2 August 2017

1 August 2005

1 reference

Nature Reviews Drug Discovery

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

649-663

1 reference

2 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1799

2 August 2017

0 references

cites work

Chemical space and biology

1 reference

Navigating chemical space for biology and medicine

31 March 2020

1 reference

Trends in virtual combinatorial library design

31 March 2020

1 reference

The de novo design of protein structures

31 March 2020

1 reference

Appreciation. Jane s. Richardson: biophysical society national lecturer 1992

31 March 2020

1 reference

Computer design of bioactive molecules: a method for receptor-based de novo ligand design

31 March 2020

1 reference

The rational design of amino acid sequences by artificial neural networks and simulated molecular evolution: de novo design of an idealized leader peptidase cleavage site

31 March 2020

1 reference

Peptide design by artificial neural networks and computer-based evolutionary search

31 March 2020

1 reference

The computer program LUDI: a new method for the de novo design of enzyme inhibitors

31 March 2020

1 reference

LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads

31 March 2020

1 reference

PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules

31 March 2020

1 reference

PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology

31 March 2020

1 reference

SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility

31 March 2020

1 reference

GroupBuild: a fragment-based method for de novo drug design

31 March 2020

1 reference

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

31 March 2020

1 reference

A genetic algorithm for the automated generation of molecules within constraints.

31 March 2020

1 reference

RASSE: a new method for structure-based drug design.

31 March 2020

1 reference

LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design

31 March 2020

1 reference

HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

31 March 2020

1 reference

An automated method for dynamic ligand design.

31 March 2020

1 reference

Functionality maps of binding sites: a multiple copy simultaneous search method

31 March 2020

1 reference

Automated site-directed drug design using molecular lattices

31 March 2020

1 reference

BUILDER v.2: improving the chemistry of a de novo design strategy.

31 March 2020

1 reference

The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.

31 March 2020

1 reference

Automated structure design in 3D

31 March 2020

1 reference

Automated site-directed drug design: approaches to the formation of 3D molecular graphs.

31 March 2020

1 reference

GenStar: a method for de novo drug design.

31 March 2020

1 reference

CONCERTS: dynamic connection of fragments as an approach to de novo ligand design

31 March 2020

1 reference

Design of new selective inhibitors of cyclooxygenase-2 by dynamic assembly of molecular building blocks.

31 March 2020

1 reference

Structure-based ligand design for flexible proteins: application of new F-DycoBlock.

31 March 2020

1 reference

Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

31 March 2020

1 reference

SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.

31 March 2020

1 reference

Target validation of G-protein coupled receptors

31 March 2020

1 reference

PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

31 March 2020

1 reference

Development and testing of a de novo drug-design algorithm

31 March 2020

1 reference

A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm.

31 March 2020

1 reference

De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks

31 March 2020

1 reference

A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules.

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

Predictive in silico modeling for hERG channel blockers

31 March 2020

1 reference

RECAP--retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry

31 March 2020

1 reference

SYNOPSIS: SYNthesize and OPtimize System in Silico

31 March 2020

1 reference

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design

31 March 2020

1 reference

SPROUT: a program for structure generation.

31 March 2020

1 reference

SPROUT: recent developments in the de novo design of molecules

31 March 2020

1 reference

SPROUT: 3D Structure Generation Using Templates

31 March 2020

1 reference

De novo design of enzyme inhibitors by Monte Carlo ligand generation

31 March 2020

1 reference

BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.

31 March 2020

1 reference

Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design

31 March 2020

1 reference

A branch-and-bound method for optimal atom-type assignment in de novo ligand design.

31 March 2020

1 reference

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

31 March 2020

1 reference

A genetic algorithm for structure-based de novo design

31 March 2020

1 reference

Recent development and application of virtual screening in drug discovery: an overview

31 March 2020

1 reference

Recent advances in de novo design strategy for practical lead identification

31 March 2020

1 reference

Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi

31 March 2020

1 reference

A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.

31 March 2020

1 reference

Molecular diversity management strategies for building and enhancement of diverse and focused lead discovery compound screening collections

31 March 2020

1 reference

A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues

31 March 2020

1 reference

Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors

31 March 2020

1 reference

Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes

31 March 2020

1 reference

A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions

31 March 2020

1 reference

High-throughput drug discovery: what can we expect from HTS?

31 March 2020

1 reference

31 March 2020

1 reference

The properties of known drugs. 1. Molecular frameworks

31 March 2020

1 reference

31 March 2020

1 reference

High-throughput chemistry and structure-based design: survival of the smartest

31 March 2020

1 reference

Using NMR for ligand discovery and optimization

31 March 2020

1 reference

Combinatorial library design using a multiobjective genetic algorithm

31 March 2020

1 reference

Superposition of three-dimensional chemical structures allowing for conformational flexibility by a hybrid method.

31 March 2020

1 reference

Optimizing the size and configuration of combinatorial libraries

31 March 2020

1 reference

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

31 March 2020

1 reference

Automated site-directed drug design: the concept of spacer skeletons for primary structure generation.

31 March 2020

1 reference

A novel computational tool for automated structure-based drug design

31 March 2020

1 reference

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

31 March 2020

1 reference

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs

31 March 2020

1 reference

PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement.

31 March 2020

1 reference

PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides

31 March 2020

1 reference

PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides

31 March 2020

1 reference

Combinatorial computational method gives new picomolar ligands for a known enzyme

31 March 2020

1 reference

Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)

31 March 2020

1 reference

Automated site-directed drug design: a general algorithm for knowledge acquisition about hydrogen-bonding regions at protein surfaces.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD1799

1 reference

2 August 2017

1 reference

PubMed ID

16056391